openPR Logo
Press release

Creative Diagnostics Announces New Zearalenone Test Reagents for Food Safety Applications

09-16-2024 07:18 PM CET | Health & Medicine

Press release from: ABNewswire

Creative Diagnostics Announces New Zearalenone Test Reagents

Creative Diagnostics announces the launch of Zearalenone Test Reagents for accurate detection of Zearalenone.
Creative Diagnostics, a leading manufacturer and supplier of antibodies, small molecule conjugates and critical assay reagents for the analysis of food, feed, environmental and toxicological samples, is pleased to announce the launch of its new Zearalenone Test Reagents [https://www.creative-diagnostics.com/food-analysis/tag-zearalenone-40.htm] for accurate and reliable detection of Zearalenone, empowering researchers, food safety professionals, and regulatory agencies to ensure the safety of food supplies worldwide.

Mycotoxins are toxic metabolites produced by various species of fungi, mainly belonging to the genera Aspergillus, Penicillium and Fusarium. Mycotoxins typically enter the food chain through contaminated food and feed crops, primarily cereals. Mycotoxins in food and feed can cause serious acute and chronic health effects in humans and animals. Therefore, the analysis of mycotoxins in food and feed is necessary and often required by law.

Zearalenone (ZEN), also known as RAL and F-2 mycotoxins, is a non-steroidal estrogenic mycotoxin produced primarily by Fusarium, which also typically produces deoxynivalenol. Therefore, there is evidence that if zearalenone is detected, there is a high probability that other Fusarium mycotoxins are present. There are several Fusarium species that produce toxins of major concern to livestock and poultry producers; these are deoxynivalenol, T-2 toxin, HT2 toxin, diacetoxyscirpenol (DAS) and zearalenone. Zearalenone is the primary toxin that can cause sterility, abortion, or other reproductive problems, particularly in swine.

Zearalenone is heat stable and is found in many cereal crops around the world, including corn, barley, oats, wheat, rice, sorghum and bread. When livestock consume feed or grain contaminated with zearalenone, a variety of reproductive problems can occur. In swine, ZEN causes vulvovaginitis, low birth weight, fetal resorption, abortion, reduced litter size, abnormal estrus, and immature male feminization. The association of zearalenone with human toxicity has not been confirmed, but it is classified as an endocrine disruptor and is considered potentially harmful to humans. There are no recommended levels, but the FDA recommends monitoring zearalenone levels of concern.

Creative Diagnostics has released a series of Zearalenone Test Reagents for the analysis of zearalenone, including antibodies, conjugates and standards. These new reagents, e.g., Zearalenon Immunoaffinity Column, Zearalenone Standard (97%), RHA Trademark anti-Zearalenone monoclonal antibody, can offer a highly sensitive and specific method for detecting and quantifying zearalenone in food samples, ideal for use in food safety laboratories, research institutions, and regulatory agencies.

Creative Diagnostics is committed to providing innovative tools that meet the evolving needs of the food industry and will continue to offer food safety professionals and researchers more reliable and sensitive solutions for monitoring mycotoxins in food samples. For more information about the company's test products and comprehensive portfolio of food safety solutions, please visit https://www.creative-diagnostics.com/food-analysis/tag-zearalenone-40.htm.

About Creative Diagnostics

Creative Diagnostics is a leading manufacturer and supplier of antibodies, small molecule conjugates and critical assay reagents for the analysis of food, feed, environmental and toxicological samples. Its product portfolio covers a wide range of analytes including mycotoxins, drug residues, pesticides, contaminants, food allergens, food pathogens and vitamins. The company also assists customers in the rapid development, manufacture and commercialization of small molecule antigens, antibodies and food safety lateral flow strips for any market segment.

Media Contact
Company Name: Creative Diagnostics
Contact Person: Thomas Schmitt
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=creative-diagnostics-announces-new-zearalenone-test-reagents-for-food-safety-applications]
State: New York
Country: United States
Website: https://www.creative-diagnostics.com/food-analysis/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Creative Diagnostics Announces New Zearalenone Test Reagents for Food Safety Applications here

News-ID: 3656991 • Views:

More Releases from ABNewswire

How to Pick the Best Online Chemistry Tutoring Platform
How to Pick the Best Online Chemistry Tutoring Platform
Image: https://www.abnewswire.com/upload/2025/10/814f4b38d9855ce5fcc0509bfebaa240.jpg Choosing the right chemistry tutoring platform can make the difference between academic success and continued struggles with complex reactions and molecular structures. With students increasingly turning to digital solutions for personalized learning support, the online chemistry tutoring market has exploded with options promising everything from AI-powered progress tracking to virtual lab experiences that transform how learners approach this challenging subject. Essential Platform Features for Effective Online Chemistry Tutoring Modern chemistry tutoring
Chronic Myeloid Leukemia Pipeline Drugs Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Chronic Myeloid Leukemia Pipeline Drugs Report 2025: Emerging Therapies, Clinica …
DelveInsight's "Chronic Myeloid Leukemia Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Chronic Myeloid Leukemia pipeline landscape. It covers the Chronic Myeloid Leukemia Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Chronic Myeloid Leukemia Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Curious
Diabetic Retinopathy Pipeline Drugs Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Diabetic Retinopathy Pipeline Drugs Report 2025: Emerging Therapies, Clinical De …
DelveInsight's, "Diabetic Retinopathy Pipeline Insights 2025" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in the Diabetic Retinopathy pipeline landscape. It covers the Diabetic Retinopathy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Retinopathy pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by
Diabetic Macular Edema Pipeline Outlook Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Diabetic Macular Edema Pipeline Outlook Report 2025: Emerging Therapies, Clinica …
DelveInsight's, "Diabetic Macular Edema Pipeline Insight 2025" report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Diabetic Macular Edema pipeline landscape. It covers the Diabetic Macular Edema pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Macular Edema pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our

All 5 Releases